Abbott Labs (ABT) Price & Analysis

Compare

8,439 Followers

ABT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$99.71 - $141.23

Previous CloseN/A

Volume1.03M

Average Volume (3M)5.87M

Market Cap

$239.05B

Enterprise Value$238.09B

Total Cash (Recent Filing)$6.84B

Total Debt (Recent Filing)$13.24B

Price to Earnings (P/E)17.9

Beta0.35

Next Earnings

Jul 17, 2025

EPS Estimate

1.25

Next Dividend Ex-Date

Jul 15, 2025

Dividend Yield1.71%

Share Statistics

EPS (TTM)1.09

Shares Outstanding1,739,836,400

10 Day Avg. Volume5,785,939

30 Day Avg. Volume5,871,912

Financial Highlights & Ratios

PEG Ratio26.64

Price to Book (P/B)4.76

Price to Sales (P/S)0.00

P/FCF Ratio34.76

Enterprise Value/Market Cap1.00

Enterprise Value/Revenue1.43

Enterprise Value/Gross Profit10.06

Enterprise Value/Ebitda5.50

Forecast

1Y Price Target

$143.26

Price Target Upside4.26% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering21

Abbott Labs News

See All News >

Bulls Say, Bears Say

Bulls Say

Market PositionABT is expected to be on track to be the US market leader in 2026, with increasing US revenue share from 37% in 2022 to 46% in 2025.

Product DevelopmentABT anticipates strong uptake for the ketone sensor based on conversations with the physician community, especially for intensive patients.

Revenue GrowthABT continues to highlight its goal for reaching $10bn in Libre revenue by 2028 and is tracking ahead of this goal.

Bears Say

Geopolitical ImpactDespite a ~$700M headwind in 2025, consisting of ~$200M from China VBP and ~$500M y/y COVID testing decline.

Market CompetitionHeightening competition in certain subsegments such as Electrophysiology could make it difficult for Abbott to achieve significant near-term upside.

Revenue ContributionThe non-MedTech segments collectively account for the majority of total company revenue but only contribute a minority of the growth, which softens the impact of Abbott’s most attractive growth drivers.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

0.47% Insiders

26.11% Mutual Funds

21.67% Other Institutional Investors

31.06% Public Companies and Individual Investors

Detailed Ownership Overview >

ABT FAQ

What was Abbott Laboratories’s price range in the past 12 months?

Abbott Laboratories lowest stock price was $99.71 and its highest was $141.23 in the past 12 months.

What is Abbott Laboratories’s market cap?

Abbott Laboratories’s market cap is $239.05B.

When is Abbott Laboratories’s upcoming earnings report date?

Abbott Laboratories’s upcoming earnings report date is Jul 17, 2025 which is in 21 days.

How were Abbott Laboratories’s earnings last quarter?

Abbott Laboratories released its earnings results on Apr 16, 2025. The company reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.072 by $0.018.

Is Abbott Laboratories overvalued?

According to Wall Street analysts Abbott Laboratories’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Abbott Laboratories pay dividends?

Abbott Laboratories pays a Quarterly dividend of $0.59 which represents an annual dividend yield of 1.71%. See more information on Abbott Laboratories dividends here

What is Abbott Laboratories’s EPS estimate?

Abbott Laboratories’s EPS estimate is 1.25.

How many shares outstanding does Abbott Laboratories have?

Abbott Laboratories has 1,739,836,400 shares outstanding.

What happened to Abbott Laboratories’s price movement after its last earnings report?

Abbott Laboratories reported an EPS of $1.09 in its last earnings report, beating expectations of $1.072. Following the earnings report the stock price went up 2.757%.

Which hedge fund is a major shareholder of Abbott Laboratories?

Currently, no hedge funds are holding shares in ABT

Abbott Labs Stock Smart Score

Outperform

Fundamentals

Return on Equity

30.66%

Trailing 12-Months

Asset Growth

12.39%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Abbott Laboratories

Abbott Laboratories (ABT) is a global healthcare company headquartered in Abbott Park, Illinois. The company operates through four main business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Abbott is known for its wide range of healthcare products, including branded generic medicines, diagnostic systems and tests, nutritional products for infants and adults, and advanced medical devices for cardiovascular, diabetes care, and neuromodulation.

ABT Company Deck

ABT Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Abbott Laboratories reported a strong financial performance with significant growth in several segments, including medical devices and nutrition, while facing challenges from tariffs and a decline in diagnostics sales, particularly in China. The company's strategic investments and product innovations provide a solid foundation for future growth, although the impact of tariffs remains a concern.Read More>

ABT Net sales Breakdown

45.26% Medical Devices

22.27% Diagnostic Products

20.05% Nutritional Products

12.38% Established Pharmaceutical Products

0.04% Other

ABT Stock 12 Month Forecast

Average Price Target

$143.26

▲(4.26%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"99":"$99","160":"$160","114.25":"$114.3","129.5":"$129.5","144.75":"$144.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":159,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$159.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":143.26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$143.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":127,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$127.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[99,114.25,129.5,144.75,160],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.57,135.52615384615385,137.4823076923077,139.43846153846152,141.39461538461538,143.35076923076923,145.30692307692308,147.2630769230769,149.21923076923076,151.17538461538462,153.13153846153847,155.0876923076923,157.04384615384615,{"y":159,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.57,134.3153846153846,135.0607692307692,135.80615384615385,136.55153846153846,137.29692307692306,138.04230769230767,138.7876923076923,139.53307692307692,140.27846153846153,141.02384615384614,141.76923076923077,142.51461538461538,{"y":143.26,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.57,133.06461538461537,132.55923076923077,132.05384615384614,131.54846153846154,131.0430769230769,130.5376923076923,130.03230769230768,129.52692307692308,129.02153846153846,128.51615384615386,128.01076923076923,127.50538461538461,{"y":127,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":100.18,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.17,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.56,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.63,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.92,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.44,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.66,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.34,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.37,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.88,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.57,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >